Procyon Advisors LLC trimmed its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 48.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,033 shares of the life sciences company’s stock after selling 5,773 shares during the period. Procyon Advisors LLC’s holdings in Illumina were […]
Vision Capital Management Inc. cut its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 2.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,666 shares of the life sciences company’s stock after selling 514 shares during the quarter. Vision Capital Management Inc.’s holdings […]
B & T Capital Management DBA Alpha Capital Management cut its holdings in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 90.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,527 shares of the life sciences company’s stock after selling 15,120 […]
OTR Global reissued their mixed rating on shares of Illumina (NASDAQ:ILMN – Free Report) in a report published on Wednesday, Benzinga reports. A number of other research analysts also recently weighed in on ILMN. TD Cowen lowered Illumina from an outperform rating to a market perform rating and set a $144.00 target price for the […]
Illumina, Inc. (NASDAQ:ILMN – Get Free Report) CEO Jacob Thaysen purchased 7,330 shares of the company’s stock in a transaction on Thursday, February 22nd. The shares were bought at an average price of $135.29 per share, for a total transaction of $991,675.70. Following the completion of the transaction, the chief executive officer now directly owns […]